When a planned intervention does not yield improvement after 6 weeks, the recommended step is to:

When a planned intervention does not yield improvement after 6 weeks, the recommended step is to:

• A. End the intervention immediately without review
• B. Increase the dosage of medication
• C. Adjust the intervention and reevaluate in 4-6 weeks
• D. Continue the same approach without changes

Answer: (C)

When a planned intervention isn’t showing improvement after a reasonable trial, the best move is to adjust the plan and reevaluate in a new cycle. This reflects a practical, data-driven approach: assess what’s working, what isn’t, and why, then modify the intervention’s components, intensity, or delivery to better fit the client’s needs. After making targeted changes, you give it another 4–6 weeks to observe the impact and gather fresh feedback from the client and relevant data. This keeps the work collaborative and responsive, and it avoids discarding potentially helpful strategies too quickly or persisting with the same method when it isn’t effective. Ending the intervention without review overlooks learning opportunities and may waste effort and resources. Increasing medication dosage should be determined by the appropriate clinical professional and based on careful assessment of risks and benefits. Continuing the same approach without changes ignores the signal that progress isn’t occurring, which is unlikely to yield better outcomes.

When a planned intervention isn’t showing improvement after a reasonable trial, the best move is to adjust the plan and reevaluate in a new cycle. This reflects a practical, data-driven approach: assess what’s working, what isn’t, and why, then modify the intervention’s components, intensity, or delivery to better fit the client’s needs. After making targeted changes, you give it another 4–6 weeks to observe the impact and gather fresh feedback from the client and relevant data. This keeps the work collaborative and responsive, and it avoids discarding potentially helpful strategies too quickly or persisting with the same method when it isn’t effective.

Ending the intervention without review overlooks learning opportunities and may waste effort and resources. Increasing medication dosage should be determined by the appropriate clinical professional and based on careful assessment of risks and benefits. Continuing the same approach without changes ignores the signal that progress isn’t occurring, which is unlikely to yield better outcomes.